Search results
Learn about HUV, a rare form of vasculitis with skin and systemic involvement, low complement levels, and possible genetic and environmental factors. Find out the symptoms, causes, diagnosis, and resources for this condition.
- Getting a Diagnosis
The following organization(s) may maintain a list of experts...
- PubMed Central (PMC)
Hypocomplementemic urticarial vasculitis syndrome (HUVS), or...
- Getting a Diagnosis
Hypocomplementemic urticarial vasculitis syndrome (HUVS), or McDuffie syndrome, is a rare disease process that was first described by McDuffie et al1 in 1973. Four patients presented with recurrent urticarial lesions and decreased serum complement.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare leukocytoclastic vasculitis characterized by recurrent urticarial lesions and hypocomplementemia, often associated with other systemic symptoms such as fever, arthralgias, arthritis, abdominal pain as well as ocular, renal, pulmonary and gastrointestinal involvement.
22 lut 2017 · Hypocomplementemic urticarial vasculitis syndrome (HUVS) is an uncommon small-vessel vasculitis presenting as a chronic urticaria with hypocomplementemia and the presence of anti-C1q autoantibodies. In most patients it is accompanied by a wide variety of extracutaneous manifestations such as arthritis, glomerulonephritis, ocular inflammation ...
17 mar 2021 · Hypocomplementemic urticarial vasculitis syndrome (HVUS) belongs to the group of systemic small-vessel vasculitis and is characterized by persistent urticarial lesions lasting more than 24 hours, hypocomplementemia and frequent coexistence of organ involvement.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is considered to be an independent immunological ... Chronic urticaria often points the way to the diagnosis of a systemic disease, particularly when urticarial vasculitis can be demonstrated.
Hypocomplementemic urticarial vasculitis (HUV) is a rare immune complex-mediated small vessel vasculitis with urticaria, hypocomplementemia and anti-C1q autoantibodies. It can affect various organs and has a variable prognosis depending on the severity of the involvement.
